- Home
- Publications
- Publication Search
- Publication Details
Title
Review of the Molecular Pathogenesis of Osteosarcoma
Authors
Keywords
-
Journal
Asian Pacific Journal of Cancer Prevention
Volume 15, Issue 15, Pages 5967-5976
Publisher
Asian Pacific Organization for Cancer Prevention
Online
2014-11-06
DOI
10.7314/apjcp.2014.15.15.5967
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Osteosarcoma
- (2016) Patrick J. Messerschmitt et al. JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS
- PIK3CA and AKT Gene Polymorphisms in Susceptibility to Osteosarcoma in a Chinese Population
- (2014) Mao-Lin He et al. Asian Pacific Journal of Cancer Prevention
- LY294002 Induces G0/G1 Cell Cycle Arrest and Apoptosis of Cancer Stem-like Cells from Human Osteosarcoma Via Down-regulation of PI3K Activity
- (2013) Chen Gong et al. Asian Pacific Journal of Cancer Prevention
- miRNA-218 Inhibits Osteosarcoma Cell Migration and Invasion by Down-regulating of TIAM1, MMP2 and MMP9
- (2013) Jie Jin et al. Asian Pacific Journal of Cancer Prevention
- Targeting HMGB1-mediated autophagy as a novel therapeutic strategy for osteosarcoma
- (2012) Jun Huang et al. Autophagy
- A systems biology approach reveals common metastatic pathways in osteosarcoma
- (2012) Ricardo J Flores et al. BMC Systems Biology
- Detection and characterisation of multi-drug resistance protein 1 (MRP-1) in human mitochondria
- (2012) E A Roundhill et al. BRITISH JOURNAL OF CANCER
- Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice
- (2012) François-Xavier Dieudonné et al. JOURNAL OF BONE AND MINERAL RESEARCH
- An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration
- (2012) Alexander B Mohseny et al. JOURNAL OF PATHOLOGY
- Glycogen Synthase Kinase-3β, NF-κB Signaling, and Tumorigenesis of Human Osteosarcoma
- (2012) Qing-Lian Tang et al. JNCI-Journal of the National Cancer Institute
- Can a Two-Faced Kinase be Exploited for Osteosarcoma?
- (2012) J. R. Woodgett JNCI-Journal of the National Cancer Institute
- A Phase I Trial of the HIV Protease Inhibitor Nelfinavir with Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-small Cell Lung Cancer: A Report of Toxicities and Clinical Response
- (2012) Ramesh Rengan et al. Journal of Thoracic Oncology
- Co-administration phenoxodiol with doxorubicin synergistically inhibit the activity of sphingosine kinase-1 (SphK1), a potential oncogene of osteosarcoma, to suppress osteosarcoma cell growth both in vivo and in vitro
- (2012) Chen Yao et al. Molecular Oncology
- Novel role of PKR in inflammasome activation and HMGB1 release
- (2012) Ben Lu et al. NATURE
- CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma
- (2012) Shih-Wei Wang et al. PLoS One
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis
- (2012) Véronique Ouellet et al. Journal of Cell Communication and Signaling
- Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials
- (2011) J. S. Whelan et al. ANNALS OF ONCOLOGY
- High-throughput genotyping in osteosarcoma identifies multiple mutations in phosphoinositide-3-kinase and other oncogenes
- (2011) Edwin Choy et al. CANCER
- IGF1R-Targeted Therapy and Its Enhancement of Doxorubicin Chemosensitivity in Human Osteosarcoma Cell Lines
- (2011) Frederick Luk et al. CANCER INVESTIGATION
- HMGB1 Promotes Drug Resistance in Osteosarcoma
- (2011) J. Huang et al. CANCER RESEARCH
- CDK redundancy guarantees cell cycle progression in RB-negative tumor cells independently of their p16 status
- (2011) Marta Santamariña et al. CELL CYCLE
- Transient treatment with CDK inhibitors eliminates proliferative potential even when their abilities to evoke apoptosis and DNA damage are blocked
- (2011) Simon F. Scrace et al. CELL CYCLE
- Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma
- (2011) Allison Marion et al. INTERNATIONAL JOURNAL OF CANCER
- ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9
- (2011) Sang-Min Kim et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Role of GLI2 in the growth of human osteosarcoma
- (2011) Hiroko Nagao et al. JOURNAL OF PATHOLOGY
- The Cyclin-Dependent Kinase Inhibitor SCH 727965 (Dinacliclib) Induces the Apoptosis of Osteosarcoma Cells
- (2011) W. Fu et al. MOLECULAR CANCER THERAPEUTICS
- Overexpression of BMI-1 Promotes Cell Growth and Resistance to Cisplatin Treatment in Osteosarcoma
- (2011) Zhihong Wu et al. PLoS One
- PEDF as a treatment for cervical cancer
- (2010) Anne R. Murray et al. CANCER BIOLOGY & THERAPY
- Smoothened as a new therapeutic target for human osteosarcoma
- (2010) Masataka Hirotsu et al. Molecular Cancer
- Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma
- (2010) E. M. Rubin et al. MOLECULAR CANCER THERAPEUTICS
- Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
- (2010) Hsiangling Teo et al. NATURE CELL BIOLOGY
- When pathways collide: collaboration and connivance among signalling proteins in development
- (2010) Helen McNeill et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Osteosarcoma incidence and survival rates from 1973 to 2004
- (2009) Lisa Mirabello et al. CANCER
- Strategies for the targeted delivery of therapeutics for osteosarcoma
- (2009) Dennis PM Hughes Expert Opinion on Drug Delivery
- In vitroandin vivobiological activity of PEDF against a range of tumors
- (2009) Matthew L Broadhead et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- CCL5/CCR5 axis promotes the motility of human oral cancer cells
- (2009) Jing-Yuan Chuang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition
- (2009) A. Rasola et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CCL5 increases lung cancer migration via PI3K, Akt and NF-κB pathways
- (2008) Chun-Yin Huang et al. BIOCHEMICAL PHARMACOLOGY
- The role of sphingosine kinase 1 in cancer: Oncogene or non-oncogene addiction?
- (2008) M VADAS BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Autophagy: A Novel Mechanism of Synergistic Cytotoxicity between Doxorubicin and Roscovitine in a Sarcoma Model
- (2008) L. A. Lambert et al. CANCER RESEARCH
- Frzb, a Secreted Wnt Antagonist, Decreases Growth and Invasiveness of Fibrosarcoma Cells Associated with Inhibition of Met Signaling
- (2008) Y. Guo et al. CANCER RESEARCH
- Targeting SphK1 as a New Strategy against Cancer
- (2008) Dai Shida et al. CURRENT DRUG TARGETS
- Bone Tumors in Adolescents and Young Adults
- (2008) Stefan S. Bielack et al. CURRENT TREATMENT OPTIONS IN ONCOLOGY
- High grade osteosarcoma of the extremities with lung metastases at presentation: Treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions
- (2008) Gaetano Bacci et al. JOURNAL OF SURGICAL ONCOLOGY
- Celecoxib, a cyclooxygenase-2 inhibitor, induces apoptosis in human osteosarcoma cell line MG-63 via down-regulation of PI3K/Akt
- (2007) B LIU et al. CELL BIOLOGY INTERNATIONAL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started